Ken Macnamara, PhD
UK Scientific and Site Head
As the UK Scientific and Site Head, Dr. Ken Macnamara is instrumental in advancing potential therapies through AskBio’s early portfolio program.
Dr. Macnamara has a wealth of R&D, business operations, financial planning, intellectual property, and quality/compliance experience gained from his time at start-up and multinational firms. He joined AskBio in 2019 after serving as Chief Operating Officer at Synpromics, a gene control synthetic promoter technology company acquired by AskBio. Dr. Macnamara began his career at the University of Edinburgh, where he earned a PhD in chemistry before helping to launch Lab901, a leading electrophoresis equipment and consumables company. There, he was a product development manager responsible for developing the TapeStation and ScreenTape technologies from concept to market success. Agilent Technologies acquired Lab901 in 2011. Dr. Macnamara then served as R&D Director for the Microfluidics business at Agilent, setting the R&D strategy and leading the team through tremendous business growth.